{
  "docId": "019de072-a06b-75fe-abfc-06d6c9b36d69",
  "docSlug": "20a8e4b0fa87449fed1951c46c728b45",
  "documentTitle": "argenx SE | Results Presentation Deck | 21 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 12,
  "pageCount": 21,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "comparison_table",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 16,
  "notes": "The table includes p-values and standard deviations for clinical metrics.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-a06b-75fe-abfc-06d6c9b36d69/12",
  "deckHref": "/decks/019de072-a06b-75fe-abfc-06d6c9b36d69",
  "deckJsonHref": "/decks/019de072-a06b-75fe-abfc-06d6c9b36d69.json",
  "deckAnchorHref": "/decks/019de072-a06b-75fe-abfc-06d6c9b36d69#slide-12",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.5,
        "x": 0.05,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "* significant at overall 5% level across study based on hierarchical statistical testing",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c5623709-3f3f-4b7f-8565-2d2ef875c074",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.9,
        "x": 0.05,
        "y": 0.268
      },
      "kind": "table",
      "text": "Key Secondary Endpoints, Population, VYVGART, Placebo, P-value",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "444376ed-b07a-4b79-8f2b-fc5d8cef9bdf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "VYVGART Showed Robust Benefit for People Living with ITP",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2aa9cc3d-4481-4e18-8543-f3ad0ebdcec0",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}